Published in Rev Med Virol on March 01, 2010
TRIM5α does not affect simian immunodeficiency virus SIV(mac251) replication in vaccinated or unvaccinated Indian rhesus macaques following intrarectal challenge exposure. J Virol (2011) 1.11
TRIM22: A Diverse and Dynamic Antiviral Protein. Mol Biol Int (2012) 1.01
TRIM27 negatively regulates NOD2 by ubiquitination and proteasomal degradation. PLoS One (2012) 0.98
TRIM5α and Species Tropism of HIV/SIV. Front Microbiol (2012) 0.96
The relationship between HIV-1 genome RNA dimerization, virion maturation and infectivity. Nucleic Acids Res (2010) 0.95
Trafficking of some old world primate TRIM5α proteins through the nucleus. Retrovirology (2011) 0.92
Ex vivo gene therapy for HIV-1 treatment. Hum Mol Genet (2011) 0.92
Insights into cellular factors that regulate HIV-1 replication in human cells. Biochemistry (2011) 0.92
Generation of rhesus macaque-tropic HIV-1 clones that are resistant to major anti-HIV-1 restriction factors. J Virol (2013) 0.89
Role of Human TRIM5α in Intrinsic Immunity. Front Microbiol (2012) 0.86
Geographical, genetic and functional diversity of antiretroviral host factor TRIMCyp in cynomolgus macaque (Macaca fascicularis). J Gen Virol (2011) 0.86
TRIM5α variations influence transduction efficiency with lentiviral vectors in both human and rhesus CD34(+) cells in vitro and in vivo. Mol Ther (2013) 0.85
Diversity of TRIM5α and TRIMCyp sequences in cynomolgus macaques from different geographical origins. Immunogenetics (2011) 0.83
Characterization of a core fragment of the rhesus monkey TRIM5α protein. BMC Biochem (2011) 0.83
The cell biology of TRIM5α. Curr HIV/AIDS Rep (2012) 0.83
Zinc-finger antiviral protein inhibits XMRV infection. PLoS One (2012) 0.83
Current progress and challenges in HIV gene therapy. Future Virol (2011) 0.82
The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5α. PLoS One (2012) 0.82
Restriction genes for retroviruses influence the risk of multiple sclerosis. PLoS One (2013) 0.82
Human endogenous retroviruses and the nervous system. Handb Clin Neurol (2014) 0.82
TRIM21: a cytosolic Fc receptor with broad antibody isotype specificity. Immunol Rev (2015) 0.81
Pigtailed macaques as a model to study long-term safety of lentivirus vector-mediated gene therapy for hemoglobinopathies. Mol Ther Methods Clin Dev (2014) 0.81
Coarse-grained simulation reveals key features of HIV-1 capsid self-assembly. Nat Commun (2016) 0.80
Breaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives. Biology (Basel) (2012) 0.80
Macaque-tropic human immunodeficiency virus type 1: breaking out of the host restriction factors. Front Microbiol (2013) 0.79
Impact of TRIM5α in vivo. AIDS (2015) 0.78
The bovine immunodeficiency virus Rev protein: identification of a novel nuclear import pathway and nuclear export signal among retroviral Rev/Rev-like proteins. J Virol (2012) 0.78
Kinetics of lentiviral vector transduction in human CD34(+) cells. Exp Hematol (2015) 0.78
The E3 ubiquitin ligase ARIH1 protects against genotoxic stress by initiating a 4EHP-mediated mRNA translation arrest. Mol Cell Biol (2015) 0.78
Allele frequency of antiretroviral host factor TRIMCyp in wild-caught cynomolgus macaques (Macaca fascicularis). Front Microbiol (2012) 0.76
Potent restriction of HIV-1 and SIVmac239 replication by African green monkey TRIM5α. Retrovirology (2015) 0.76
Novel mutant human immunodeficiency virus type 1 strains with high degree of resistance to cynomolgus macaque TRIMCyp generated by random mutagenesis. J Gen Virol (2016) 0.75
The ubiquitin ligase TRIM27 functions as a host restriction factor antagonized by Mycobacterium tuberculosis PtpA during mycobacterial infection. Sci Rep (2016) 0.75
Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization. J Biol Chem (2007) 1.79
Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J Exp Med (2002) 1.43
A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas. J Virol (2007) 1.32
Possible role of dimerization in human immunodeficiency virus type 1 genome RNA packaging. J Virol (2003) 1.22
HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients. AIDS Res Ther (2009) 1.08
Dissociation of genome dimerization from packaging functions and virion maturation of human immunodeficiency virus type 1. J Virol (2002) 1.06
Improved capacity of a monkey-tropic HIV-1 derivative to replicate in cynomolgus monkeys with minimal modifications. Microbes Infect (2010) 1.05
Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults. AIDS Res Ther (2010) 1.04
A CCR2-V64I polymorphism affects stability of CCR2A isoform. AIDS (2004) 1.03
Anti-retroviral drug resistance-associated mutations among non-subtype B HIV-1-infected Kenyan children with treatment failure. J Med Virol (2007) 1.02
Comparison of anti-viral activity of rhesus monkey and cynomolgus monkey TRIM5alphas against human immunodeficiency virus type 2 infection. Virology (2008) 1.01
Contribution of RING domain to retrovirus restriction by TRIM5alpha depends on combination of host and virus. Virology (2010) 0.99
Influence of glycosylation on the efficacy of an Env-based vaccine against simian immunodeficiency virus SIVmac239 in a macaque AIDS model. J Virol (2005) 0.98
Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5α-mediated restriction. Retrovirology (2010) 0.97
Protective effect of interleukin-4 -589T polymorphism on human immunodeficiency virus type 1 disease progression: relationship with virus load. J Infect Dis (2002) 0.97
Minimal region sufficient for genome dimerization in the human immunodeficiency virus type 1 virion and its potential roles in the early stages of viral replication. J Virol (2007) 0.97
RANTES -28G delays and DC-SIGN - 139C enhances AIDS progression in HIV type 1-infected Japanese hemophiliacs. AIDS Res Hum Retroviruses (2007) 0.96
TRIM5α and Species Tropism of HIV/SIV. Front Microbiol (2012) 0.96
HIV-2 capsids distinguish high and low virus load patients in a West African community cohort. Vaccine (2010) 0.95
The relationship between HIV-1 genome RNA dimerization, virion maturation and infectivity. Nucleic Acids Res (2010) 0.95
The polymorphisms in DC-SIGNR affect susceptibility to HIV type 1 infection. AIDS Res Hum Retroviruses (2007) 0.94
A single amino acid substitution of the human immunodeficiency virus type 1 capsid protein affects viral sensitivity to TRIM5 alpha. Retrovirology (2010) 0.91
Retro-transduction by virus pseudotyped with glycoprotein of vesicular stomatitis virus. Virology (2007) 0.91
Wild type and H43Y variant of human TRIM5alpha show similar anti-human immunodeficiency virus type 1 activity both in vivo and in vitro. Immunogenetics (2007) 0.91
Generation of rhesus macaque-tropic HIV-1 clones that are resistant to major anti-HIV-1 restriction factors. J Virol (2013) 0.89
Silencing of tripartite motif protein (TRIM) 5alpha mediated anti-HIV-1 activity by truncated mutant of TRIM5alpha. J Virol Methods (2008) 0.89
Impact of novel TRIM5alpha variants, Gly110Arg and G176del, on the anti-HIV-1 activity and the susceptibility to HIV-1 infection. AIDS (2009) 0.88
Protective effects of IL4-589T and RANTES-28G on HIV-1 disease progression in infected Thai females. AIDS (2006) 0.88
TIM1 haplotype may control the disease progression to AIDS in a HIV-1-infected female cohort in Thailand. AIDS (2010) 0.88
Gag-CA Q110D mutation elicits TRIM5-independent enhancement of HIV-1mt replication in macaque cells. Microbes Infect (2012) 0.87
An efficient and versatile mammalian viral vector system for major histocompatibility complex class I/peptide complexes. J Virol (2002) 0.87
A naturally occurring single amino acid substitution in human TRIM5α linker region affects its anti-HIV type 1 activity and susceptibility to HIV type 1 infection. AIDS Res Hum Retroviruses (2013) 0.87
A single amino acid of human immunodeficiency virus type 2 capsid protein affects conformation of two external loops and viral sensitivity to TRIM5α. PLoS One (2011) 0.87
A proposal for a new HIV-1 DLS structural model. Nucleic Acids Res (2012) 0.86
Role of Human TRIM5α in Intrinsic Immunity. Front Microbiol (2012) 0.86
Geographical, genetic and functional diversity of antiretroviral host factor TRIMCyp in cynomolgus macaque (Macaca fascicularis). J Gen Virol (2011) 0.86
Impact of a single amino acid in the variable region 2 of the Old World monkey TRIM5alpha SPRY (B30.2) domain on anti-human immunodeficiency virus type 2 activity. Virology (2009) 0.85
Systemic biological analysis of the mutations in two distinct HIV-1mt genomes occurred during replication in macaque cells. Microbes Infect (2013) 0.84
New Rev-transport inhibitor with anti-HIV activity from Valerianae Radix. Bioorg Med Chem Lett (2002) 0.83
TRIM5 genotypes in cynomolgus monkeys primarily influence inter-individual diversity in susceptibility to monkey-tropic human immunodeficiency virus type 1. J Gen Virol (2013) 0.83
The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5α. PLoS One (2012) 0.82
Slower uncoating is associated with impaired replicative capability of simian-tropic HIV-1. PLoS One (2013) 0.81
TRIM5alpha-independent anti-human immunodeficiency virus type 1 activity mediated by cyclophilin A in Old World monkey cells. Virology (2008) 0.81
Polymorphisms in Fas gene is associated with HIV-related lipoatrophy in Thai patients. AIDS Res Hum Retroviruses (2012) 0.80
Development of a rapid and convenient method for the quantification of HIV-1 budding. Microbes Infect (2006) 0.80
Electrostatic potential of human immunodeficiency virus type 2 and rhesus macaque simian immunodeficiency virus capsid proteins. Front Microbiol (2012) 0.80
Genetic analysis of HIV-1 discordant couples in Thailand: association of CCR2 64I homozygosity with HIV-1-negative status. J Acquir Immune Defic Syndr (2002) 0.79
Elicitation of both anti HIV-1 Env humoral and cellular immunities by replicating vaccinia prime Sendai virus boost regimen and boosting by CD40Lm. PLoS One (2012) 0.79
Direct correlation between genome dimerization and recombination efficiency of HIV-1. Microbes Infect (2010) 0.79
Impact of TRIM5α in vivo. AIDS (2015) 0.78
A dominant-negative effect of cynomolgus monkey tripartite motif protein TRIM5alpha on anti-simian immunodeficiency virus SIVmac activity of an African green monkey orthologue. Virology (2006) 0.78
Effects of CCR2 and CCRS polymorphisms on HIV-1 infection in Thai females. J Acquir Immune Defic Syndr (2008) 0.77
Comparison between Sendai virus and adenovirus vectors to transduce HIV-1 genes into human dendritic cells. J Med Virol (2008) 0.77
Allele frequency of antiretroviral host factor TRIMCyp in wild-caught cynomolgus macaques (Macaca fascicularis). Front Microbiol (2012) 0.76
A rapid recombination assay of HIV-1 using murine CD52 as a novel biomarker. Microbes Infect (2008) 0.76
No significant enhancement of protection by Tat-expressing Sendai viral vector-booster in a macaque AIDS model. AIDS (2003) 0.76
Effects of human interleukin 7 on HIV-1 replication in monocyte-derived human macrophages. AIDS (2006) 0.75
Influence of ABCB-1 C3435T polymorphisms on plasma nevirapine and efavirenz levels and their effects on virologic and immunological outcomes in HIV/TB co-infected Thai adults under anti-retroviral therapy. Southeast Asian J Trop Med Public Health (2012) 0.75
[TRIM5alpha]. Uirusu (2005) 0.75
Induction of HIV-1-specific neutralizing antibodies in mice vaccinated with a recombinant Sendai virus vector. Jpn J Infect Dis (2002) 0.75
[Host genetic polymorphisms in the pathogenesis of HIV-1 disease]. Nihon Rinsho (2002) 0.75
Host genetic analysis of HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression. AIDS Res Hum Retroviruses (2007) 0.75
Properties of human immunodeficiency virus type 1 reverse transcriptase recombination upon infection. J Gen Virol (2015) 0.75